Citation Tools

Original research
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

Download to a citation manager

Cite this article as:
Siddiqui BA, Gheeya JS, Goswamy R, et al
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events